Mark S. Verratti serves as the Chief Commercial Officer at Myriad Genetics, Inc., a leading precision medicine company focused on genetic testing and analysis. With a robust background in the life sciences and healthcare industries, Verratti has been instrumental in driving Myriad Genetics' commercial strategies and growth initiatives. Prior to joining Myriad Genetics, he held various leadership positions at prominent companies such as Quest Diagnostics, where he served as Senior Vice President of Commercial Operations, and Thermo Fisher Scientific, where he was Vice President of Sales for the Genetic Sciences Division. At Myriad Genetics, Verratti is responsible for overseeing the company's global commercial operations, including sales, marketing, and customer support. His strategic vision and leadership have been pivotal in expanding the company's reach and enhancing its product offerings. Under his guidance, Myriad Genetics has successfully launched several innovative genetic testing solutions that have significantly improved patient outcomes and advanced personalized medicine. Verratti's ability to foster strong relationships with healthcare providers and payers has been crucial in positioning Myriad Genetics as a leader in the genetic testing market. Verratti's achievements extend beyond his role at Myriad Genetics. He is recognized in the industry for his contributions to advancing healthcare through genomics and his commitment to improving patient care. Verratti holds a Bachelor of Science degree in Biology from the University of California, San Diego, and an MBA from the Kellogg School of Management at Northwestern University. His blend of scientific knowledge and business acumen has made him a respected figure in the field of precision medicine, and he continues to drive innovation and growth at Myriad Genetics.